Pediatric vitiligo.
Study Design
- Тип исследования
- Review
- Популяция
- Children with vitiligo
- Вмешательство
- Pediatric vitiligo. None
- Препарат сравнения
- None
- Первичный исход
- Pediatric vitiligo management
- Направление эффекта
- Positive
- Риск систематической ошибки
- Unclear
Abstract
Vitiligo is a disease of pigment loss. Most investigators currently consider vitiligo to be a disorder that occurs as a result of autoimmune destruction of melanocytes, supported by identification of antimelanocyte antibodies in many patients, and the presence of comorbid autoimmune disease in patients with and family members of individuals with vitiligo. One-half of vitiligo cases are of childhood onset. This article presents a current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations.
Кратко
A current overview of pediatric vitiligo including comorbidities of general health, psychological factors, therapeutic options, and long-term health considerations is presented.
Used In Evidence Reviews
Similar Papers
BMJ (Clinical research ed.) · 2022
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
American journal of clinical dermatology · 2018
Vitamin D and the Skin: An Update for Dermatologists.
The Cochrane database of systematic reviews · 2012
Dietary supplements for established atopic eczema.
Journal of the American Academy of Dermatology · 2014
Diet and psoriasis, part III: role of nutritional supplements.
The British journal of dermatology · 2014
Vitamin D deficiency in alopecia areata.
Postepy dermatologii i alergologii · 2016